Vigilare Wealth Management’s Exact Sciences EXAS Stock Holding History

Vigilare Wealth Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,640	Closed	-$347K	–	184
2021 Q3	$347K	Buy	3,640 +525	+17%	+$55.4K	0.21%	134
2021 Q2	$387K	Buy	3,115 +885	+40%	+$106K	0.23%	118
2021 Q1	$294K	Buy	2,230 +330	+17%	+$45.2K	0.21%	136
2020 Q4	$252K	Sell	1,900 -1,100	-37%	-$133K	0.24%	100
2020 Q3	$306K	Sell	3,000 -750	-20%	-$64.8K	0.32%	75
2020 Q2	$326K	Sell	3,750 -900	-19%	-$71.9K	0.33%	68
2020 Q1	$270K	Buy	4,650 +1,549	+50%	+$126K	0.32%	80
2019 Q4	$293K	Buy	+3,101	New	+$273K	0.2%	109

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vigilare Wealth Management's EXAS Position: Q4 2021 in Review

Vigilare Wealth Management sold out of Exact Sciences (EXAS) in Q4 2021, closing a stake of 3,640 shares — an estimated $347K sold.

Vigilare Wealth Management first reported a position in EXAS in Q4 2019 and held it in 8 quarters. The position peaked at $387K in Q2 2021. 596 funds tracked by Wall St. Rank hold EXAS as of Q4 2021.

Vigilare Wealth Management reported no remaining Exact Sciences position as of Q4 2021 after selling out during the quarter.
Vigilare Wealth Management sold 3,640 Exact Sciences shares in Q4 2021, an estimated $347K.
Vigilare Wealth Management first reported a position in Exact Sciences in Q4 2019 and held it in 8 quarters.
Vigilare Wealth Management's Exact Sciences position peaked at $387K in Q2 2021.
596 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2021.

Based on Vigilare Wealth Management's 13F filing for Q4 2021, filed 7 Jan 2022.